Louis Sullivan

Directeur/Membre du Conseil chez UNITED THERAPEUTICS CORPORATION Fortune : 3 M $ au 30/04/2024

Profil

Louis Wade Sullivan founded Medical Education for South African Blacks, where he worked as Chairman.
Dr. Sullivan also currently works at The Sullivan Alliance, as Chairman & Chief Executive Officer from 2014, Henry Schein Cares Foundation, Inc., as Co-Chairman, United Therapeutics Corp., as Independent Director from 2002, Emergent BioSolutions, Inc., as Independent Director from 2006, Morehouse School of Medicine, as President from 1993 to 2002, and America's Public Television Stations, as Trustee from 2011.
Dr. Sullivan also formerly worked at ANI Pharmaceuticals, Inc., as Non-Executive Chairman from 2011 to 2013, The National Health Museum, as Chairman, Public Broadcasting Atlanta, as Chairman, South African Blacks, Inc., as Chairman-Medical Education, Bristol Myers Squibb Co., as Independent Director, Cigna Holding Co., as Director from 1993 to 2006, Equifax, Inc., as Director, General Motors Corp., as Director, Georgia-Pacific LLC, as Director, Household International, Inc., as Director, 3M Co., as Director, Henry Schein, Inc., as Independent Director from 2003 to 2016, ANI Pharmaceuticals, Inc., as Director, Inhibitex LLC, as Director, Africare, Inc., as Director, Project HOPE-The-People-To-People HealthFoundation, Inc., as Director, Partnership To End Addiction, as Director, Boston University Medical Center Hospital, as Co-Director-Hematology Division, The Cigna Group, as Director, Seton Hall University, as Assistant Professor in 1965, Boy Scouts of America, as Member-National Executive Council, Little League Baseball, Inc., as Trustee, US Department of Health & Human Services (DC), as Secretary from 1989 to 1993, Morehouse School of Medicine, as President from 1981 to 1989, and Boston University School of Medicine, as Professor in 1975.
Dr. Sullivan received his undergraduate degree in 1954 from Morehouse College and doctorate degree in 1958 from Boston University School of Medicine.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
UNITED THERAPEUTICS CORPORATION 0,03%	03/05/2024	13 060 ( 0,03% )	3 M $	30/04/2024
EMERGENT BIOSOLUTIONS INC. 0,20%	23/05/2024	104 695 ( 0,20% )	222 694 $	30/04/2024
ANI PHARMACEUTICALS, INC. 25,56%	15/03/2024	2 777 ( 25,56% )	180 366 $	30/04/2024

Postes actifs de Louis Sullivan

Sociétés	Poste	Début
UNITED THERAPEUTICS CORPORATION	Directeur/Membre du Conseil	01/01/2002
EMERGENT BIOSOLUTIONS INC.	Directeur/Membre du Conseil	01/06/2006
America's Public Television Stations	Directeur/Membre du Conseil	10/01/2011
The Sullivan Alliance	Directeur Général	-
Henry Schein Cares Foundation, Inc.	Président	-
Morehouse School of Medicine	Directeur/Membre du Conseil	01/01/2002

Anciens postes connus de Louis Sullivan

Sociétés	Poste	Fin
HENRY SCHEIN, INC.	Directeur/Membre du Conseil	01/06/2016
ANI PHARMACEUTICALS, INC.	Président	19/06/2013
Inhibitex LLC	Directeur/Membre du Conseil	19/09/2007
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░

Formation de Louis Sullivan

Morehouse College	Undergraduate Degree
Boston University School of Medicine	Doctorate Degree